Empire Asset Management Company Initiates Coverage

News provided by

Empire Asset Management Company

Jan 31, 2013, 08:43 ET

NEW YORK, Jan. 31, 2013 /PRNewswire/ -- Empire Asset Management Company a FINRA member (143007) initiated coverage today on Alnylam Pharmaceuticals Inc, (NASDAQ: ALNY) with a Sell rating and 12 month price target $14.00.

SOURCE Empire Asset Management Company

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED